Outcomes after salvage allogeneic stem cell transplantation with myeloablative conditioning FBC in patients with relapsed/refractory mantle cell lymphoma: single-center experience

被引：0
|
作者：
Aydilek, E. [1 ]
Hasenkamp, J. [1 ]
Aperdannier, L. [1 ]
Maulhardt, M. [1 ]
Mazzeo, P. [1 ]
Shumilov, E. [2 ]
Wulf, G. [1 ]
机构：
[1] Univ Klinikum Gottingen, Hamatol & Med Onkol, Gottingen, Germany
[2] Univ Klinikum Munster, Hamatol & Onkol, Munster, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1081
引用
收藏
页码：304 / 305
页数：2
相关论文
共 50 条
  • [31] THE ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN RELAPSED HODGKIN LYMPHOMA: A SINGLE CENTER EXPERIENCE
    Couto, Maria Eduarda
    Pinho, Vaz Carlos
    Bras, Gil
    Leite, Luis
    Ferreira, Rosa
    Roncon, Susana
    Campos, Junior Antonio
    HAEMATOLOGICA, 2020, 105 : 269 - 269
  • [32] Allogeneic stem cell transplantation in elderly lymphoma patients: Single center experience
    Gulbas, Zafer
    Atesoglu, Elif Birtas
    Sengezer, Meral
    Dora, Imran
    Eren, Cigdem
    Celik, Suat
    Cekdemir, Demet
    BONE MARROW TRANSPLANTATION, 2019, 54 : 470 - 471
  • [33] Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory mantle cell lymphoma
    Yamasaki, Satoshi
    Chihara, Dai
    Kim, Sung-Won
    Izutsu, Koji
    Iwato, Kouji
    Fukuda, Takahiro
    Uchida, Naoyuki
    Amano, Itsuto
    Nakazawa, Hideyuki
    Kuroda, Junya
    Hashimoto, Hisako
    Ichinohe, Tatsuo
    Kanda, Yoshinobu
    Atsuta, Yoshiko
    Suzumiya, Junji
    Suzuki, Ritsuro
    ANNALS OF HEMATOLOGY, 2018, 97 (08) : 1445 - 1452
  • [34] Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory mantle cell lymphoma
    Satoshi Yamasaki
    Dai Chihara
    Sung-Won Kim
    Koji Izutsu
    Kouji Iwato
    Takahiro Fukuda
    Naoyuki Uchida
    Itsuto Amano
    Hideyuki Nakazawa
    Junya Kuroda
    Hisako Hashimoto
    Tatsuo Ichinohe
    Yoshinobu Kanda
    Yoshiko Atsuta
    Junji Suzumiya
    Ritsuro Suzuki
    Annals of Hematology, 2018, 97 : 1445 - 1452
  • [35] AUTOLOGOUS STEM CELL TRANSPLANTATION FOR MANTLE CELL LYMPHOMA: SINGLE CENTER EXPERIENCE
    Toprak, S. K.
    Atilla, E.
    Atilla, P. Ataca
    Bozdag, S. Civriz
    Yuksel, M. Kurt
    Topcuoglu, P.
    Demirer, T.
    Arslan, O.
    Ozcan, M.
    Arat, M.
    Ilhan, O.
    Akan, H.
    Beksac, M.
    Konuk, N.
    Uysal, A.
    Gurman, G.
    HAEMATOLOGICA, 2017, 102 : 865 - 865
  • [36] Allogeneic hematopoietic cell transplant for relapsed-refractory, marginal zone lymphoma: a single-center experience
    Dholaria, Bhagirathbhai R.
    Hammond, William A.
    Roy, Vivek
    Sher, Taimur
    Vishnu, Prakash
    Soyano, Aixa
    Finn, Laura E.
    Tun, Han
    LEUKEMIA & LYMPHOMA, 2018, 59 (11) : 2727 - 2730
  • [37] Outcomes of allogeneic hematopoietic stem cell transplantation (HCT) after non-myeloablative conditioning in relapsed, refractory, or transformed indolent non-hodgkin lymphoma (NHL).
    Rezvani, Andrew R.
    Sandmaier, Brenda M.
    Storer, Barry
    Maris, Michael
    Agura, Edward
    Maziarz, Richard
    Wade, James C.
    Chauncey, Thomas
    Forman, Stephen J.
    Niederwieser, Dietger W.
    Shizuru, Judith
    Langston, Amelia
    Pulsipher, Michael
    Storb, Rainer F.
    Maloney, David G.
    BLOOD, 2006, 108 (11) : 891A - 891A
  • [38] Nivolumab after allogeneic hematopoietic stem cell transplantation in relapsed/refractory hodgkin's lymphoma (RR-HL) - A single center experience
    Moreira, A.
    Viegas, D.
    Teixeira, G.
    Ferreira, I.
    Miranda, N.
    Moita, F.
    Jorge, A. S.
    Gutierrez, M. J.
    Leal da Costa, F.
    Abecasis, M.
    BONE MARROW TRANSPLANTATION, 2019, 54 : 468 - 469
  • [39] Allogeneic stem cell transplantation in relapsed or refractory Hodgkin's lymphoma: A report of 9 patients treated at a single center
    Villalobos, M.
    Schonland, S.
    Meissner, J.
    Rieger, M.
    Hegenbart, U.
    Dreger, P.
    Ho, A. D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 81 - 82
  • [40] Daratumumab as salvage therapy in relapsed/refractory multiple myeloma patients after allogeneic stem cell transplantation
    Essmann, S.
    von Pein, U. -M.
    Klyuchnikov, E.
    Janson, D.
    Bonmann, S.
    Ayuk, F. A.
    Wolschke, C.
    Kroeger, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 190 - 190
12345